Determination of the critical diabetes duration in a streptozotocin-induced diabetic rat calvarial defect model for experimentation regarding bone regeneration
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to determine the critical diabetes duration in a streptozotocin (STZ)-induced diabetic rat calvarial defect model for experimentation regarding bone regeneration by evaluating the association between diabetes duration and bone healing capacity through histological and radiographic analyses. Methods: Experimental diabetes was induced in 50 of 60 rats by an STZ injection. The rats were divided into 5 groups, including a control group (group 1), according to diabetes durations of 0, 2, 4, 6, and 8 weeks, respectively. Eighteen rats survived: 4 in group 1, 4 in group 2, 4 in group 3, 5 in group 4, and 1 in group 5. Calvarial defects were created at 0, 2, 4, 6, and 8 weeks after STZ injection in groups 1–5. Cone-beam computed tomography scanning was performed at baseline and at 5 and 7 weeks after surgery. The rats were sacrificed 7 weeks after surgery, followed by histological evaluation. Results: The voxel gray values (VGVs) of group 1 and group 2 increased, whereas the VGVs of group 3 and group 4 decreased starting 5 weeks after surgery, although this trend did not reach statistical significance between groups. On the reconstructed 3-dimensional images and based on an analysis of histological features, groups 1 and 2 showed apparent bone regeneration, while groups 3–5 showed very limited bone regeneration. Conclusions: The critical diabetes duration in an STZ-induced diabetic rat calvarial defect model for experimentation regarding bone regeneration was between 2 and 4 weeks. It is suggested that researchers who use STZ-induced diabetic rats wait for more than 2 weeks following diabetes induction before placing implants or conducting bone regeneration studies to allow definite disturbances in bone healing to emerge.
Abstract
Purpose: The purpose of this study was to determine the critical diabetes duration in a streptozotocin (STZ)-induced diabetic rat calvarial defect model for experimentation regarding bone regeneration by evaluating the association between diabetes duration and bone healing capacity through histological and radiographic analyses. Methods: Experimental diabetes was induced in 50 of 60 rats by an STZ injection. The rats were divided into 5 groups, including a control group (group 1), according to diabetes durations of 0, 2, 4, 6, and 8 weeks, respectively. Eighteen rats survived: 4 in group 1, 4 in group 2, 4 in group 3, 5 in group 4, and 1 in group 5. Calvarial defects were created at 0, 2, 4, 6, and 8 weeks after STZ injection in groups 1–5. Cone-beam computed tomography scanning was performed at baseline and at 5 and 7 weeks after surgery. The rats were sacrificed 7 weeks after surgery, followed by histological evaluation. Results: The voxel gray values (VGVs) of group 1 and group 2 increased, whereas the VGVs of group 3 and group 4 decreased starting 5 weeks after surgery, although this trend did not reach statistical significance between groups. On the reconstructed 3-dimensional images and based on an analysis of histological features, groups 1 and 2 showed apparent bone regeneration, while groups 3–5 showed very limited bone regeneration. Conclusions: The critical diabetes duration in an STZ-induced diabetic rat calvarial defect model for experimentation regarding bone regeneration was between 2 and 4 weeks. It is suggested that researchers who use STZ-induced diabetic rats wait for more than 2 weeks following diabetes induction before placing implants or conducting bone regeneration studies to allow definite disturbances in bone healing to emerge.
참고문헌 (40)
- Zarb GA, "The longitudinal clinical effectiveness of osseointegrated dental implants: the Toronto study. Part I: surgical results", J Prosthet Dent, 63, pp.451~457 (1990)
- Dohan Ehrenfest DM, "Classification of osseointegrated implant surfaces: materials, chemistry and topography", Trends Biotechnol, 28, pp.198~206 (2010)
- Neukam FW, "Flemmig TFWorking Group 3. Local and systemic conditions potentially compromising osseointegration. Consensus report of Working Group 3", Clin Oral Implants Res, 17(Suppl 2), pp.160~162 (2006)
- Oates TW, "A critical review of diabetes, glycemic control, and dental implant therapy", Clin Oral Implants Res, 24, pp.117~127 (2013)
- Albandar JM, "Global epidemiology of periodontal diseases : an overview", Periodontol 2000, 29, pp.7~10 (2002)
- D'Aiuto F, "Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey", J Clin Endocrinol Metab, 93, pp.3989~3994 (2008)
- Danaei G, "National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants", Lancet, 378, pp.31~40 (2011)
- Korean Diabeties Association, "Diabetes fact sheet in Korea 2016", Korean Diabetes Association, ~ (2016)
- Khader YS, "Periodontal status of diabetics compared with nondiabetics : a meta-analysis", J Diabetes Complications, 20, pp.59~68 (2006)
- Rothwell BR, "Diabetes mellitus : medical and dental considerations", Spec Care Dentist, 4, pp.58~65 (1984)
- McMahon MM, "Host defenses and susceptibility to infection in patients with diabetes mellitus", Infect Dis Clin North Am, 9, pp.1~9 (1995)
- Davis PH, "Risk factors for ischemic stroke: a prospective study in Rochester, Minnesota", Ann Neurol, 22, pp.319~327 (1987)
- Mankovsky BN, "Stroke in patients with diabetes mellitus", Diabetes Metab Res Rev, 20, pp.268~287 (2004)
- Auwerx J, "Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus", Diabetes, 37, pp.8~12 (1988)
- Bouillon R, "Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus", J Clin Endocrinol Metab, 80, pp.1194~1202 (1995)
- Schwartz AV, "Diabetes, fracture, and bone fragility", Curr Osteoporos Rep, 5, pp.105~111 (2007)
- Siqueira JT, "Bone formation around titanium implants in the rat tibia : role of insulin", Implant Dent, 12, pp.242~251 (2003)
- de Morais JA, "Effect of diabetes mellitus and insulin therapy on bone density around osseointegrated dental implants : a digital subtraction radiography study in rats", Clin Oral Implants Res, 20, pp.796~801 (2009)
- Hasegawa H, "Type 2 diabetes impairs implant osseointegration capacity in rats", Int J Oral Maxillofac Implants, 23, pp.237~246 (2008)
- Motyl K, "Streptozotocin, type I diabetes severity and bone", Biol Proced Online, 11, pp.296~315 (2009)
- Takeshita F, "The effects of diabetes on the interface between hydroxyapatite implants and bone in rat tibia", J Periodontol, 68, pp.180~185 (1997)
- Takeshita F, "Uncontrolled diabetes hinders bone formation around titanium implants in rat tibiae. A light and fluorescence microscopy, and image processing study", J Periodontol, 69, pp.314~320 (1998)
- Nevins ML, "Wound healing around endosseous implants in experimental diabetes", Int J Oral Maxillofac Implants, 13, pp.620~629 (1998)
- Giglio MJ, "Histomorphometric study of bone healing around laminar implants in experimental diabetes", Implant Dent, 9, pp.143~149 (2000)
- Cooper GM, "Testing the critical size in calvarial bone defects : revisiting the concept of a critical-size defect", Plast Reconstr Surg, 125, pp.1685~1692 (2010)
- Schmitz JP, "The critical size defect as an experimental model for craniomandibulofacial nonunions", Clin Orthop Relat Res, pp.299~308 (1986)
- Muzzarelli RL., "Chitin, chitosan, oligosaccharides and their derivatives", pp.223~240 (2010), CRC Press
- Szkudelski T, "The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas", Physiol Res, 50, pp.537~546 (2001)
- Taylor AM, "Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats : prevention by insulin treatment and correlation with skeletal growth", Endocrinology, 121, pp.1360~1365 (1987)
- Wohaieb SA, "Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment", Diabetes, 36, pp.1014~1018 (1987)
- Zhang XF, "Effects of an ethanolic extract of Gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats", Singapore Med J, 41, pp.9~13 (2000)
- Martinez H, "Optimal implant stabilization in low density bone", Clin Oral Implants Res, 12, pp.423~432 (2001)
- Duckmanton NA, "Imaging for predictable maxillary implants", Int J Prosthodont, 7, pp.77~80 (1994)
- Norton MR, "Bone classification : an objective scale of bone density using the computerized tomography scan", Clin Oral Implants Res, 12, pp.79~84 (2001)
- Parsa A, "Reliability of voxel gray values in cone beam computed tomography for preoperative implant planning assessment", Int J Oral Maxillofac Implants, 27, pp.1438~1442 (2012)
- Cassetta M, "How accurate is CBCT in measuring bone density? A comparative CBCT-CT in vitro study", Clin Implant Dent Relat Res, 16, pp.471~478 (2014)
- Taylor GW, "Glycemic control and alveolar bone loss progression in type 2 diabetes", Ann Periodontol, 3, pp.30~39 (1998)
- Hajna Z, "Modeling long-term diabetes and related complications in rats", J Pharmacol Toxicol Methods, 78, pp.1~12 (2016)
- Shyng YC, "The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat", Int J Oral Maxillofac Surg, 30, pp.70~74 (2001)
- Kwon PT, "Maintenance of osseointegration utilizing insulin therapy in a diabetic rat model", J Periodontol, 76, pp.621~626 (2005)